$71.04 -0.85 (%) Astrazeneca Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Jan. 30, 2015 | 04:00 PM

Partner Headlines

  1. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  2. Benzinga's Volume Movers

    Benzinga | Jan. 27, 2015 | 10:42AM EST
  3. Leerink Raises AstraZeneca Price Target

    Benzinga | Jan. 22, 2015 | 12:15PM EST
  4. Barclays Issues 3 Upgrades, 1 Downgrade On Pharma Stocks

    Benzinga | Jan. 16, 2015 | 15:12PM EST
  5. Merck Takes A Step Forward In The World Of Medicine

    GuruFocus | Jan. 16, 2015 | 11:23AM EST
  6. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  7. QIAGEN Announces First-ever Regulatory Registration of a Lung Cancer Companion Diagnostic Based on Liquid Biopsies in Collaboration With AstraZeneca

    Benzinga | Jan. 12, 2015 | 04:51AM EST
  8. What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts

    Benzinga | Jan. 9, 2015 | 12:53PM EST
  9. Pfizer, Home of Lipitor and Viagra, Lifts Dividend

    IBD | Dec. 31, 2014 | 17:16PM EST
  10. FDA's OKs may prescribe hits

    IBD | Dec. 26, 2014 | 18:49PM EST
  11. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  12. AstraZeneca

    IBD | Dec. 19, 2014 | 18:25PM EST
  13. Meet 5 Big Tech Stocks Expected To See Profits Surge

    IBD | Dec. 16, 2014 | 19:46PM EST
  14. Merck's Keytruda Might Treat Virulent Breast Cancer

    IBD | Dec. 10, 2014 | 11:04AM EST
  15. Morgan Stanley Pair Trade On Novartis And AstraZeneca

    Benzinga | Dec. 2, 2014 | 14:01PM EST
  16. Meet 5 Top Drug Stocks That Are Bolting Past Market

    IBD | Dec. 2, 2014 | 08:02AM EST
  17. 5 Stock-Moving Medtech Events This December

    IBD | Nov. 28, 2014 | 14:18PM EST
  18. AstraZeneca CEO: We Will Achieve Our Targets Through Our Drug Pipeline

    Benzinga | Nov. 28, 2014 | 10:53AM EST
  19. CNBC'S Catherine Boyle Doesn't Think A Pfizer/AstraZeneca Deal Will Happen Soon

    Benzinga | Nov. 26, 2014 | 14:20PM EST
  20. AMGEN

    IBD | Nov. 25, 2014 | 18:47PM EST
  21. ISIS-STAT3 Rx And ISIS-AR Rx Data Presented By AstraZeneca At European Cancer Symposium

    Benzinga | Nov. 20, 2014 | 16:48PM EST
  22. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  23. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  24. Bank Of America Believes DAPT Adds To Precedent For PEGASUS Success For AstraZeneca

    Benzinga | Nov. 17, 2014 | 10:29AM EST
  25. Report: Pfizer 'Unlikely' To Pursue Acquisition Of AstraZeneca

    Benzinga | Nov. 14, 2014 | 09:38AM EST
  26. Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis

    Benzinga | Nov. 11, 2014 | 16:03PM EST
  27. Blackhill Bets Almost Half of Portfolio on Williams-Sonoma

    GuruFocus | Nov. 10, 2014 | 16:00PM EST
  28. A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio

    GuruFocus | Nov. 9, 2014 | 18:16PM EST
  29. Medivation Hits High After Q3 Earnings Beat

    IBD | Nov. 7, 2014 | 11:15AM EST
  30. Medivation Hits High After Q3 Earnings Beat

    IBD | Nov. 7, 2014 | 11:15AM EST
  31. #PreMarket Primer: Friday, November 7: Boehner Reveals Intentions To Modify Obamacare

    Benzinga | Nov. 7, 2014 | 07:50AM EST
  32. Will Pfizer Sweeten Its Bid For AstraZeneca?

    IBD | Nov. 6, 2014 | 18:41PM EST
  33. Divided Government Won't Halt Wall Street's Run

    FoxBusiness | Nov. 6, 2014 | 09:58AM EST
  34. #PreMarket Primer: Thursday, November 6: Obama, McConnell Prepare For Rocky Road Ahead

    Benzinga | Nov. 6, 2014 | 08:08AM EST
  35. AstraZeneca Raises 2014 Outlook

    Benzinga | Nov. 6, 2014 | 06:14AM EST
  36. Markets Rally On Better-Than-Expected GDP; Dow Has Best Close In Over A Month

    Benzinga | Oct. 30, 2014 | 17:09PM EST
  37. Eliquis revives Bristol-Myers

    IBD | Oct. 24, 2014 | 18:27PM EST
  38. Bristol-Myers Beats Q3 Views As Eliquis Revives

    IBD | Oct. 24, 2014 | 13:23PM EST
  39. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD | Oct. 18, 2014 | 08:02AM EST
  40. Illumina Helps Make Gene Sequencing Affordable

    IBD | Oct. 17, 2014 | 18:48PM EST
  41. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  42. Illumina Pads Gene Sequencing Lead With Pharma Deals

    IBD | Oct. 8, 2014 | 16:04PM EST
  43. Actavis, Jazz, Novo Lead Top World Stocks List

    IBD | Oct. 7, 2014 | 18:08PM EST
  44. Actavis rival results positive

    IBD | Oct. 1, 2014 | 18:43PM EST
  45. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD | Oct. 1, 2014 | 12:10PM EST
  46. Tax Inversions Help Push Global M&A To 7-Year High

    IBD | Sep. 29, 2014 | 18:33PM EST
  47. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  48. European Stocks Fall Most In 11 Weeks; CAC-40 Off 1.9%

    IBD | Sep. 23, 2014 | 18:48PM EST
  49. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  50. Inversions Thwarted, But Real Tax Fix Needs Congress

    IBD | Sep. 23, 2014 | 18:28PM EST
Trading Center